10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20

10x Genomics Blog10x Genomics: Atera Platform Launch Advances Spatial Biology With Single-Cell Resolution At Scale - Pulse 2.0

Lonza NewsSimulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Australia

IlluminaCSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina

FierceBiotechAACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave rises

FierceBiotechRacing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS dataset

FierceBiotechRoche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials

Lonza NewsProject Hope Foundation receives $50K donation from Lonza Capsugel - Greenville Journal

FierceBiotechPulnovo Medical scores $100M in finance round led by Medtronic

IlluminaCSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina

Lonza NewsLonza Group AG stock (CH0013841017): Why biopharma contract manufacturing now matters more for U.S. - AD HOC NEWS

Dandong Aolong Radiative Instrument Group Co.,LtdWho Are the Top Competitors in the Bulk Petroleum and Chemical Storage Market Today - Weekly Voice

Dandong Aolong Radiative Instrument Group Co.,LtdCompetitive Developments in the Industrial X-Ray Market: Strategies to Watch - Weekly Voice